Related Experiment Videos
Angioplasty in severe heart attack. Anesthesia and general management
1Istituto Policlinico S. Donato, Department of Cardiothoracic Anesthesia, San Donato Milanese, Milan, Italy. cardioanestesia@virgilio.it
Insights
Coronary artery bypass graft surgery after failed percutaneous transluminal coronary angioplasty does not worsen patient outcomes. This finding is crucial for managing acute coronary syndromes and myocardial infarction patients undergoing revascularization.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Percutaneous transluminal coronary angioplasty (PTCA) is a common treatment for acute coronary syndromes.
- PTCA, whether primary or as rescue angioplasty, improves outcomes for acute myocardial infarction patients.
- Approximately 10% of PTCA procedures fail, necessitating coronary artery bypass graft (CABG) surgery, often in patients with a higher risk profile.
Purpose of the Study:
- To evaluate the outcomes of patients undergoing CABG after failed PTCA compared to the general CABG population.
- To determine if a failed PTCA impacts the prognosis for patients requiring subsequent surgical revascularization.
Main Methods:
- Analysis of 3,296 patients who underwent CABG surgery over a two-year period.
- Comparison of outcomes between patients operated on after failed PTCA and the overall CABG cohort.
Main Results:
- No significantly worsened outcomes were observed in patients who underwent CABG following a failed primary PTCA.
- The study population included 3,296 consecutive coronary patients undergoing surgical revascularization.
Conclusions:
- Surgical revascularization after failed PTCA does not appear to be associated with adverse outcomes in this patient cohort.
- The impact of GPIIb-IIIa inhibitors on postoperative bleeding requires further investigation, likely dependent on drug specifics and timing.
Background:
Percutaneous transluminal coronary angioplasty is more and more widely applied for the treatment of acute coronary syndromes. Both if primary employed or following an unsuccessful thrombolytic treatment (rescue angioplasty), it improves the early and late outcome of acute myocardial infarction patients. Anyway, in about 10% of the cases, it fails and must be followed by a coronary artery bypass graft operation. In this case, the patients reach the operating theater with a risk profile that differs from the usual one due to the higher rate of cardiogenic shock (4.5 vs 0.4%), need for intra-aortic balloon pumping (14 vs 0.8%), use of antiaggregants and heparin.
Methods:
3,296 patients who underwent coronary artery bypass graft operation over the last two years were analysed.
Results:
Despite this, in our population of coronary patients undergone surgical revascularization (3,296 consecutive patients in the last two years), we could not find a worsened outcome in patients being operated after a failed primary percutaneous transluminal coronary angioplasty.
Conclusions:
The role of GPIIb-IIIa inhibitors in determining an excessive postoperative bleeding still remains to be defined, but probably mainly depends on the type of drug, its dose, and the time between its administration and the operation.